These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 27481666)

  • 1. The Use of Rule-Based and QSPR Approaches in ADME Profiling: A Case Study on Caco-2 Permeability.
    Pham-The H; González-Álvarez I; Bermejo M; Garrigues T; Le-Thi-Thu H; Cabrera-Pérez MÁ
    Mol Inform; 2013 Jun; 32(5-6):459-79. PubMed ID: 27481666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Provisional classification and in silico study of biopharmaceutical system based on caco-2 cell permeability and dose number.
    Pham-The H; Garrigues T; Bermejo M; González-Álvarez I; Monteagudo MC; Cabrera-Pérez MÁ
    Mol Pharm; 2013 Jun; 10(6):2445-61. PubMed ID: 23675957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ADME evaluation in drug discovery. 5. Correlation of Caco-2 permeation with simple molecular properties.
    Hou TJ; Zhang W; Xia K; Qiao XB; Xu XJ
    J Chem Inf Comput Sci; 2004; 44(5):1585-600. PubMed ID: 15446816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ADME Properties Evaluation in Drug Discovery: Prediction of Caco-2 Cell Permeability Using a Combination of NSGA-II and Boosting.
    Wang NN; Dong J; Deng YH; Zhu MF; Wen M; Yao ZJ; Lu AP; Wang JB; Cao DS
    J Chem Inf Model; 2016 Apr; 56(4):763-73. PubMed ID: 27018227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modeling Caco-2 permeability of drugs using immobilized artificial membrane chromatography and physicochemical descriptors.
    Chan EC; Tan WL; Ho PC; Fang LJ
    J Chromatogr A; 2005 Apr; 1072(2):159-68. PubMed ID: 15887485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparative study of artificial membrane permeability assay for high throughput profiling of drug absorption potential.
    Zhu C; Jiang L; Chen TM; Hwang KK
    Eur J Med Chem; 2002 May; 37(5):399-407. PubMed ID: 12008054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In Silico Assessment of ADME Properties: Advances in Caco-2 Cell Monolayer Permeability Modeling.
    Pham-The H; Cabrera-Pérez MÁ; Nam NH; Castillo-Garit JA; Rasulev B; Le-Thi-Thu H; Casañola-Martin GM
    Curr Top Med Chem; 2018; 18(26):2209-2229. PubMed ID: 30499410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In Silico Prediction of Caco-2 Cell Permeability by a Classification QSAR Approach.
    Pham The H; González-Álvarez I; Bermejo M; Mangas Sanjuan V; Centelles I; Garrigues TM; Cabrera-Pérez MÁ
    Mol Inform; 2011 Apr; 30(4):376-85. PubMed ID: 27466954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implementation of an ADME enabling selection and visualization tool for drug discovery.
    Stoner CL; Gifford E; Stankovic C; Lepsy CS; Brodfuehrer J; Prasad JV; Surendran N
    J Pharm Sci; 2004 May; 93(5):1131-41. PubMed ID: 15067690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring different strategies for imbalanced ADME data problem: case study on Caco-2 permeability modeling.
    Pham-The H; Casañola-Martin G; Garrigues T; Bermejo M; González-Álvarez I; Nguyen-Hai N; Cabrera-Pérez MÁ; Le-Thi-Thu H
    Mol Divers; 2016 Feb; 20(1):93-109. PubMed ID: 26643659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A perspective on the physicochemical and biopharmaceutic properties of marketed antiseizure drugs-From phenobarbital to cenobamate and beyond.
    Odi R; Bibi D; Wager T; Bialer M
    Epilepsia; 2020 Aug; 61(8):1543-1552. PubMed ID: 32614073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimation of ADME properties in drug discovery: predicting Caco-2 cell permeability using atom-based stochastic and non-stochastic linear indices.
    Castillo-Garit JA; Marrero-Ponce Y; Torrens F; García-Domenech R
    J Pharm Sci; 2008 May; 97(5):1946-76. PubMed ID: 17724669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. QSPR model for Caco-2 cell permeability prediction using a combination of HQPSO and dual-RBF neural network.
    Wang Y; Chen X
    RSC Adv; 2020 Nov; 10(70):42938-42952. PubMed ID: 35514900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In silico model of drug permeability across sublingual mucosa.
    Goswami T; Kokate A; Jasti BR; Li X
    Arch Oral Biol; 2013 May; 58(5):545-51. PubMed ID: 23123066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Caco-2 cell permeability vs human gastrointestinal absorption: QSPR analysis.
    Ren S; Lien EJ
    Prog Drug Res; 2000; 54():1-23. PubMed ID: 10857384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. QSAR Prediction of Passive Permeability in the LLC-PK1 Cell Line: Trends in Molecular Properties and Cross-Prediction of Caco-2 Permeabilities.
    Sherer EC; Verras A; Madeira M; Hagmann WK; Sheridan RP; Roberts D; Bleasby K; Cornell WD
    Mol Inform; 2012 Apr; 31(3-4):231-45. PubMed ID: 27477094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An integrated drug-likeness study for bicyclic privileged structures: from physicochemical properties to in vitro ADME properties.
    Han C; Zhang J; Zheng M; Xiao Y; Li Y; Liu G
    Mol Divers; 2011 Nov; 15(4):857-76. PubMed ID: 21538133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ADME evaluation in drug discovery. 7. Prediction of oral absorption by correlation and classification.
    Hou T; Wang J; Zhang W; Xu X
    J Chem Inf Model; 2007; 47(1):208-18. PubMed ID: 17238266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting Caco-2 permeability using support vector machine and chemistry development kit.
    Guangli M; Yiyu C
    J Pharm Pharm Sci; 2006; 9(2):210-21. PubMed ID: 16959190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends in Molecular Properties, Bioavailability, and Permeability across the Bayer Compound Collection.
    O' Donovan DH; De Fusco C; Kuhnke L; Reichel A
    J Med Chem; 2023 Feb; 66(4):2347-2360. PubMed ID: 36752336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.